Showing results (331-340 of 491) with videos related to
Sort By:
Pageof 50
European Journal of Heart Failure|March 9, 2021
Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fractionEmil Wolsk, David M Kaye, Jan Komtebedde, et al.Circulation. Heart Failure|July 19, 2011
Central and peripheral blood flow during exercise with a continuous-flow left ventricular assist device: constant versus increasing pump speed: a pilot studyPatrice Brassard, Annette S Jensen, Nikolai Nordsborg, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2016
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trialLars Gullestad, Hans Eiskjaer, Finn Gustafsson, et al.JHLT Open|August 21, 2025
Risk prediction model for waitlist mortality in patients with left ventricular assist devicesAnjan Tibrewala, Duc Thinh Pham, Mo Hu, et al.Journal of the American College of Cardiology|December 4, 2020
Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection FractionMassar Omar, Jesper Jensen, Peter H Frederiksen, et al.Scandinavian Journal of Immunology|January 3, 2024
Differences in toll-like receptor ligand-induced cytokine concentrations before and after solid organ transplantation: A prospective, observational cohort study in a clinical settingDina Leth Møller, Søren Schwartz Sørensen, Michael Perch, et al.The International Journal of Cardiovascular Imaging|October 20, 2021
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trialMads Ersbøll, Mikkel Jürgens, Philip Hasbak, et al.Journal of the American Heart Association|July 19, 2021
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE TrialMikkel Jürgens, Morten Schou, Philip Hasbak, et al.European Journal of Heart Failure|March 20, 2013
Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study)Morten Schou, Finn Gustafsson, Lars Videbaek, et al.European Journal of Heart Failure|August 11, 2025
A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trialJames E Udelson, Steven R Goldsmith, Daniel Burkhoff, et al.Pageof 50